SCHEMBL3628049

SCHEMBL3628049

O=C1Oc2cc(O)ccc2CN1c1ccc2ccccc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 7/20 0.63
HDAC3 O15379 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
CYP1A2 P05177 2/20 0.40
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
ALDH1A1 P00352 3/20 0.38
HPGD P15428 2/20 0.38
LMNA P02545 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSP90AA1 P07900 1/20 0.37
USP2 O75604 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
ALOX15 P16050 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2765855 0.85 MIF (0.63) MIFHDAC3HDAC1HDAC2ESR1
SCHEMBL2765998 0.85 MIF (0.70) MIFHDAC3HDAC1HDAC2ESR1
SCHEMBL2766364 0.84 MIF (0.65) MIFHDAC3HDAC1HDAC2ESR1
SCHEMBL26938963 0.80 MIF (0.67) MIFHDAC3HDAC1HDAC2ALDH1A1
SCHEMBL2766991 0.80 MIF (0.74) MIFHDAC3HDAC1HDAC2ESR1
SCHEMBL2765280 0.79 MIF (0.50) MIFHDAC3HDAC1HDAC2CYP1A2
SCHEMBL19985159 0.78 MIF (0.61) MIFHDAC3HDAC1HDAC2ESR1
SCHEMBL3625289 0.77 MIF (0.54) MIFHDAC3HDAC1HDAC2ALDH1A1
SCHEMBL2766942 0.77 MIF (0.60) MIFHDAC3HDAC1HDAC2ESR1
SCHEMBL2766883 0.77 MIF (0.60) MIFHDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795251-B2 3,4-dihydro-benzo[e][1,3]oxazin-2-ones NOVARTIS AG (CH) 2010-09-14 US disclosed
EP-1874742-A1 3,4-DIHYDRO-BENZO[E][1,3]OXAZIN-2-ONES Novartis AG (CH) 2008-01-09 EP disclosed
WO-2006108671-A1 3,4-DIHYDRO-BENZO[E][1,3]OXAZIN-2-ONES NOVARTIS AG (CH) 2006-10-19 WO disclosed